143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim
Neck scan could predict risk of developing cognitive decline

Neck scan could predict risk of developing cognitive decline

by Rowan Walker,University College LondonRed blood cells. Credit: PixabayA five-minute scan of blood vessels in the neck during mid-life could predict cognitive decline ten years before symptoms

Neck scan could predict risk of developing cognitive decline

by Rowan Walker,University College LondonRed blood cells. Credit: PixabayA five-minute scan of blood vessels in the neck during mid-life could predict cognitive decline ten years before symptoms
No clinical symptoms in study of Alzheimer's transmissibility

No clinical symptoms in study of Alzheimer's transmissibility

by Medical University of ViennaMedUni Vienna researchers have published the results of a clarifying research study on the potential transmissibility of Alzheimer's disease. Although the prote

No clinical symptoms in study of Alzheimer's transmissibility

by Medical University of ViennaMedUni Vienna researchers have published the results of a clarifying research study on the potential transmissibility of Alzheimer's disease. Although the prote
A common risk factor for Alzheimer's disease may predispose carriers to severe COVID-19

A common risk factor for Alzheimer's disease may predispose carriers to severe COVID-19

by University of HelsinkiCredit: Pixabay/CC0 Public DomainA study conducted at the University of Helsinki and the Helsinki University Hospital (HUS) suggests that the APOE4 allele may also increa

A common risk factor for Alzheimer's disease may predispose carriers to severe COVID-19

by University of HelsinkiCredit: Pixabay/CC0 Public DomainA study conducted at the University of Helsinki and the Helsinki University Hospital (HUS) suggests that the APOE4 allele may also increa
Research to tackle the triple challenge of dementia, hearing and vision impairment

Research to tackle the triple challenge of dementia, hearing and vision impairment

by University of ManchesterThe combined impact of dementia, age-related hearing and vision impairment is to be investigated by a new multi-million European research consortium led by The Universi

Research to tackle the triple challenge of dementia, hearing and vision impairment

by University of ManchesterThe combined impact of dementia, age-related hearing and vision impairment is to be investigated by a new multi-million European research consortium led by The Universi
New brain discovery could help in the fight against obesity

New brain discovery could help in the fight against obesity

byUniversity of AberdeenCredit:Current Biology(2024). DOI: 10.1016/j.cub.2024.02.074One of the largest threats to human health is obesity, but now researchers from the University of

New brain discovery could help in the fight against obesity

byUniversity of AberdeenCredit:Current Biology(2024). DOI: 10.1016/j.cub.2024.02.074One of the largest threats to human health is obesity, but now researchers from the University of
Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not
Professional classical musicians are not protected from dementia

Professional classical musicians are not protected from dementia

by University of HelsinkiListening and practicing music have been reported to have many beneficial effects on human health. The effect of music on human brain has been previously studied in young

Professional classical musicians are not protected from dementia

by University of HelsinkiListening and practicing music have been reported to have many beneficial effects on human health. The effect of music on human brain has been previously studied in young
Transcranial direct current stimulation found to be safe, effective for tardive dyskinesia

Transcranial direct current stimulation found to be safe, effective for tardive dyskinesia

by Lori SolomonTranscranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically hospitalized

Transcranial direct current stimulation found to be safe, effective for tardive dyskinesia

by Lori SolomonTranscranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically hospitalized
Estrogen drug may not benefit women with Alzheimer's dementia

Estrogen drug may not benefit women with Alzheimer's dementia

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.An estrogen-like drug, raloxifene, has no demonstrated benefit on me

Estrogen drug may not benefit women with Alzheimer's dementia

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.An estrogen-like drug, raloxifene, has no demonstrated benefit on me